A recent study investigating the cardiovascular contribution to COPD symptoms and their relationship to a patient's diagnostic status found that patients with suspicious echocardiographic findings were undiagnosed and untreated.
Cardiovascular disease is often associated with chronic obstructive pulmonary disease (COPD). A recent study investigating the cardiovascular contribution to COPD symptoms and their relationship to a patient's diagnostic status found that patients with suspicious echocardiographic findings were undiagnosed and untreated.
The research, published in the International Journal of Chronic Obstructive Pulmonary Disease, included data from the German COPD cohort COSYCONET (COPD and Systemic Consequences—Comorbidities Network). Lung function data was collected including forced expiratory volume in 1 second (FEV1) and echocardiographic data on the left ventricular ejection fraction (LVEF) and end-diastolic diameter (LVEDD).
“The diagnosis of the predominant underlying disease and its contribution to COPD symptoms remains challenging. The situation is complicated by the fact that, even when objective measures of heart function are available, they do not necessarily correlate with the magnitude of symptoms,” the authors explained. “In addition, patients may receive cardiovascular medication, which may alleviate symptoms to a variable degree, depending on the type and severity of cardiac disease. Moreover, the indication that led to medication in the past might not be verifiable at a later time.”
In total, 1591 patients were included and evaluated in the study. In 289 of these patients, ischemic heart disease, myocardial infarction or heart failure was reported, while 860 patients had received at least one cardiovascular medication. Furthermore, of the 948 patients without isolated hypertension, 38% had LVEF <50% and 53.4% with LVEDD>56 mm, who lacked cardiac diagnosis and medication.
In addition, the researchers found that LVEDD and LVEF were linked to medical history, as LVEDD as dependent on residual volume/total lung capacity and LVEF on FEV1.
“The present study revealed a substantial prevalence of cardiac disease in patients with stable COPD, in accordance with previous findings. At least one of the three selected cardiac disorders was reported by about one-fifth of the patients, while the rate of suspicious echocardiographic left heart findings was lower,” concluded the authors. “The overlap between reported cardiac history and abnormal echocardiography was low, and only a minority of patients with a respective history exhibited an impaired left ventricular systolic function or dilatation.”
Due to the results, the researchers suggest that the direct assessment of heart size and function is likely to be more reliable in the detection of concomitant cardiac disease in COPD patients.
Reference
Alter P, Mayerhofer BA, Kahnert K, et al. Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort [published online September 20, 2019]. International Journal of Chronic Obstructive Pulmonary Disease. doi.org/10.2147/COPD.S209343.
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
Study: Decreased BMI Increases Severe Exacerbation, All-Cause Mortality Risk in Patients With COPD
April 10th 2024Decreased body mass index (BMI) in patients with chronic obstructive pulmonary disease (COPD) was linked to a higher risk of severe exacerbations and all-cause mortality, emphasizing the importance of monitoring BMI for managing COPD and predicting outcomes.
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
Dose-Escalation, Low-Dose Regimens May Improve Roflumilast Treatment Adherence in Patients With COPD
March 24th 2024This study suggests that dose-escalation or low-dose regimens for roflumilast treatment in patients with chronic obstructive pulmonary disease (COPD) may improve adherence.
Read More
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More